Skip to Main Content

Advertisement

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 132, Issue 9
August 30 2018
Issue Cover

Table of Contents

BLOOD COMMENTARIES

CLINICAL TRIALS AND OBSERVATIONS
IVIg and FcγRIIb in kids with ITP: individualizing therapy
Clinical Trials & Observations
Jenny M. Despotovic,James B. Bussel
View Articletitled, IVIg and FcγRIIb in kids with ITP: individualizing therapy
Hematopoiesis and Stem Cells
Mitochondria confirmed as drivers of HSC fate
Claudia Piccoli,Nazzareno Capitanio
View Articletitled, Mitochondria confirmed as drivers of HSC fate
MYELOID NEOPLASIA
Non-Ph variants in CML: guilty drivers?
Satu Mustjoki
View Articletitled, Non-Ph variants in CML: guilty drivers?

PLENARY PAPER

CLINICAL TRIALS AND OBSERVATIONS
Intravenous immunoglobulin vs observation in childhood immune thrombocytopenia: a randomized controlled trial
Clinical Trials & Observations
Katja M. J. Heitink-Pollé,Cuno S. P. M. Uiterwaal,Leendert Porcelijn,Rienk Y. J. Tamminga,Frans J. Smiers,Nicole L. van Woerden,Judit Wesseling,Gestur Vidarsson,Annemieke G. Laarhoven,Masja de Haas,Marrie C. A. Bruin,for the TIKI Investigators
View Articletitled, Intravenous immunoglobulin vs observation in childhood immune thrombocytopenia: a randomized controlled trial
Supplemental data

SPECIAL REPORT

High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies
Clinical Trials & Observations
Peter Dreger,Paolo Ghia,Johannes Schetelig,Michel van Gelder,Eva Kimby,Mauricette Michallet,Carol Moreno,Tadeusz Robak,Stephan Stilgenbauer,Emili Montserrat,on behalf of the European Research Initiative on CLL (ERIC) and the European Society for Blood and Marrow Transplantation (EBMT)
View Articletitled, High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies
Supplemental data

REVIEW ARTICLE

The role of ADAMTS13 testing in the diagnosis and management of thrombotic microangiopathies and thrombosis
Clinical Trials & Observations
Camila Masias,Spero R. Cataland
View Articletitled, The role of ADAMTS13 testing in the diagnosis and management of thrombotic microangiopathies and thrombosis

HEMATOPOIESIS AND STEM CELLS

SRC-3 is involved in maintaining hematopoietic stem cell quiescence by regulation of mitochondrial metabolism in mice
Mengjia Hu,Hao Zeng,Shilei Chen,Yang Xu,Song Wang,Yong Tang,Xinmiao Wang,Changhong Du,Mingqiang Shen,Fang Chen,Mo Chen,Cheng Wang,Jining Gao,Fengchao Wang,Yongping Su,Junping Wang
View Articletitled, SRC-3 is involved in maintaining hematopoietic stem cell quiescence by regulation of mitochondrial metabolism in mice
Supplemental data

IMMUNOBIOLOGY AND IMMUNOTHERAPY

Oncogene-specific T cells fail to eradicate lymphoma-initiating B cells in mice
Dana Hoser,Christian Schön,Christoph Loddenkemper,Philipp Lohneis,Anja A. Kühl,Thomas Sommermann,Thomas Blankenstein,Gerald Willimsky
View Articletitled, Oncogene-specific T cells fail to eradicate lymphoma-initiating B cells in mice
Supplemental data

LYMPHOID NEOPLASIA

RhoA G17V is sufficient to induce autoimmunity and promotes T-cell lymphomagenesis in mice
Samuel Y. Ng,Leon Brown,Kristen Stevenson,Tiffany deSouza,Jon C. Aster,Abner Louissaint, Jr,David M. Weinstock
View Articletitled, RhoA G17V is sufficient to induce autoimmunity and promotes T-cell lymphomagenesis in mice
Supplemental data

MYELOID NEOPLASIA

Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease
Clinical Trials & Observations
Susan Branford,Paul Wang,David T. Yeung,Daniel Thomson,Adrian Purins,Carol Wadham,Nur Hezrin Shahrin,Justine E. Marum,Nathalie Nataren,Wendy T. Parker,Joel Geoghegan,Jinghua Feng,Naranie Shanmuganathan,Martin C. Mueller,Christian Dietz,Doris Stangl,Zoe Donaldson,Haley Altamura,Jasmina Georgievski,Jodi Braley,Anna Brown,Christopher Hahn,Ieuan Walker,Soo-Hyun Kim,Soo-Young Choi,Sa-Hee Park,Dong-Wook Kim,Deborah L. White,Agnes S. M. Yong,David M. Ross,Hamish S. Scott,Andreas W. Schreiber,Timothy P. Hughes
View Articletitled, Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease
Supplemental data

THROMBOSIS AND HEMOSTASIS

Structure of an extended β3 integrin
Dongwen Zhou,Aye Myat Myat Thinn,Yan Zhao,Zhengli Wang,Jieqing Zhu
View Articletitled, Structure of an extended β<sub>3</sub> integrin
Supplemental data

LETTER TO BLOOD

Familial risks of acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms
Clinical Trials & Observations
Amit Sud,Subhayan Chattopadhyay,Hauke Thomsen,Kristina Sundquist,Jan Sundquist,Richard S. Houlston,Kari Hemminki
View Articletitled, Familial risks of acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms
Supplemental data

BLOOD WORK

PCL mimicking vHCL: a rare morphological variant
Biswadip Hazarika,Rajive Kumar
View Articletitled, PCL mimicking vHCL: a rare morphological variant

ERRATUM

Scheicher R, Hoelbl-Kovacic A, Bellutti F, et al. CDK6 as a key regulator of hematopoietic and leukemic stem cell activation. Blood. 2015;125(1):90-101.
View Articletitled, Scheicher R, Hoelbl-Kovacic A, Bellutti F, et al. CDK6 as a key regulator of hematopoietic and leukemic stem cell activation. <em>Blood.</em> 2015;125(1):90-101.
All Issues

Advertisement

Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy
NGS-based stratification refines the risk stratification in T-ALL and identifies a Very High-Risk subgroup of patients
Foxo1 is an iron-responsive transcriptional factor regulating systemic iron homeostasis
How I Treat Low-risk Polycythemia Vera Patients who Require Cytoreduction
How I manage major hemorrhage

Advertisement

Advertisement

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement